INTRODUCTION
Olmesartan medoxomil (Figure 1 ) chemically it is 4-(1-Hydroxy-1-methylethyl)-2-propyl-1- [[2'-(1H-tetazol-5-yl) [1, 1'-biphenyl]-4-yl] methyl]-1H-imidazole-5-carboxylic acid (5-Methyl-2-oxo-1, 3-dioxol-4-yl) methyl ester. It works by blocking a substance in the body that causes blood vessels to tighten. As a result, olmesartan relaxes blood vessels. This lowers blood pressure and increases the supply of blood and oxygen to the heart (The Merck Index). Hydrochlorothiazide ( Figure 2 ) is 6-Chloro-3, 4-dihydro-2H-1, 2, 4-benzothiadiazine-7-sulfonamide 1, 1-dioxide. It reduces the amount of water in the body by increasing the flow of urine, which helps lower the blood pressure (Black, 2009) .Olmesartan medoxomil and Hydrochlorothiazide are introduced into the market in combined dosage form, which is widely used in the treatment of hypertension. Literature review reveals that the methods for olmesartan and hydrochlorothiazide alone or in combined dosage forms are Development and Validation of Spectrophotometric and RP-HPLC Method for Estimation of Olmesartan Medoxomil in Tablet dosage form (Jain et al., 2010 (Nagavalli et al., 2011 
EXPERIMENTAL
Chromatographic Conditions: Olmesartan medoxomil & hydrochlorothiazide reference standards was supplied by M/s Microlabs limited, Bangalore, India. HPLC grade Acetonitrile was purchased from Merck (Mumbai, India) and triethanolamine and orthophosphoric acid from Merck (Mumbai, India). All chemicals were of analytical grade. The determination was carried out on Waters HPLC 2690 equipped with PDA 996 as detector using data handling system -waters empower 2.0 software. The column used in the development for the determination is INERTSIL ODS C18 (150 x 4.6, 5µ). The detector wavelength was set at 225nm for both the components. A flow rate of 1ml/min was used for the determination of olmesartan and hydrochlorothiazide. The samples and standards were dissolved in diluent (water: ACN, 30:70) and 10µL sample were injected into HPLC system at the column and sample temperature of 30°C.
Mobile phase 1.0 ml of Triethanolamine was mixed with 1000mL of milli Q water and pH was adjusted to 2.5±0.05 with Orthophospharic acid, filtered through 0.45μm Membrane filter. pH 2.5 Triethanolamine: Acetonitrile mixture used as a mobile phase injected into the system through a gradient flow indicated in Table 1 . 
RESULTS AND DISCUSSION
The conditions tested for method development (Table 2) indicates that all the system suitability parameters according to ICH guidelines was achieved by using INERTSIL ODS C18 (150 x 4.6, 5µ) column using mobile phase Triethanolamine in water and the pH was adjusted to 2.5 with Orthophosphoric acid and acetonitrile using a gradient program with a flow rate of 1ml/min throughout the gradient program with a detection wavelength of 225nm for both the compounds with a injection volume of 10µl (Figure 3 ).
To validate the RP-HPLC method, a series of tests were made using the most promising conditions. A calibration curve was made and concentration examined within the detection range of 25-150µg/ml & 15-90µg/ml for olmesartan & hydrochlorothiazide and correlation coefficient was found to be 0.99988 & 0.99984 for both the compounds respectively. The precision (expressed as the relative standard deviation (RSD) was determined for olmesartan & hydrochlorothiazide for repeated analysis and the values are presented in Table 4 . The assay values obtained by proposed method and recovery experiment values obtained were performed by adding a fixed amount of drug to preanalysed formulation summarized in Table 3 and Table 5 .
The stability of sample was checked by forced degradation in different conditions and % of degradation was calculated. The peak purity of the analyte was passed in all conditions (purity angle should be less than the threshold value). The following values in Table 6 indicate that any other impurity is not merging with the main peak ( Figure  4-8) . The analyte solution was stable up to 24hrs.The reliability of the method was determined by made small deliberate variations in method parameters and the RSD values (Table 7) obtained, an indication of its reliability on normal usage. A method was developed for the determination of olmesartan & hydrochlorothiazide in tablets which is rapid, stable & specific. The results indicate that the described method can be used for quantitative analysis of the compounds.
